2019-07 |
ATP-binding cassette transporter, ABCG2, activation is responsible for chemo-resistant, SIK3 low expressed ovarian cancer |
Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 5146. |
|
2019-07 |
Cathepsin S inhibition alleviates oxaliplatin-induced peripheral neuropathy through regulation of Ca2+homeostasis |
Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 2942. |
|
2019-06-24 |
Alteration of epigenetic modifiers in pancreatic cancer and its clinical implication |
Journal of Clinical Medicine. 2019 Jun 24;8(6):Article number 903. |
|
2019-06-21 |
Identification of phenothiazine as an ETV1targeting agent in gastrointestinal stromal tumors using the Connectivity Map |
International Journal of Oncology. 2019 Jun 21;55(2):536-546. |
|
2019-06-14 |
Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion |
Nature Communications. 2019 Jun 14;10:Article number 2625. |
|
2019-06-10 |
Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma |
BMC Cancer. 2019 Jun 10;19:Article number 560. |
|
2019-06-06 |
Interferon-stimulated gene 15 modulates cell migration by interacting with Rac1 and contributes to lymph node metastasis of oral squamous cell carcinoma cells |
Oncogene. 2019 Jun 9;38(23):4480-4495. |
|
2019-06-01 |
Laminin gamma2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via intergrin alpha3-dependent uptake by lymphatic endothelial cells |
International Journal of Cancer. 2019 Jun 1;144(11):2795-2810. |
|
2019-06 |
Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial |
Head and Neck. 2019 Jun;41(6):1703-1712. |
|
2019-06 |
Validation of alcohol flushing questionnaire to identify ALDH2 status in a case-control study of head and neck cancer |
Alcoholism, Clinical and Experimental Research. 2019 Jun;43(6):1225-1233. |
|
2019-06 |
MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1 |
Journal of Experimental and Clinical Cancer Research. 2019 Jun;38:Article number 281. |
|
2019-06 |
Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: A study protocol |
BMC Cancer. 2019 Jun;19:Article number 640. |
|
2019-06 |
Comparison of oncologic outcomes in laparoscopic versus open surgery for non-metastatic colorectal cancer: Personal experience in a single institution |
Journal of Clinical Medicine. 2019 Jun;8(6):Article number 875. |
|
2019-05-28 |
ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma |
Cell Death and Disease. 2019 May 28;10(6):Article number 408. |
|
2019-05-27 |
Deciphering the potential role of hox genes in pancreatic cancer |
Cancers. 2019 May 27;11(5):Article number 734. |
|
2019-05-20 |
Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer |
Molecular Cancer. 2019 May 20;18:Article number 96. |
|
2019-05-17 |
Next viable routes to targeting pancreatic cancer stemness: Learning from clinical setbacks |
Journal of Clinical Medicine. 2019 May 17;8(5):Article number 702. |
|
2019-05 |
The relationship between air pollution and lung cancer in non-smokers in Taiwan |
Journal of Thoracic Oncology. 2019 May;14(5):784-792. |
|
2019-05 |
Association of daily aspirin therapy with risk of hepatocellular carcinoma in patients with chronic hepatitis B |
JAMA Internal Medicine. 2019 May 18;179(5):633-640. |
|
2019-05 |
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial |
Journal of Geriatric Oncology. 2019 May;10(3):427-435. |
|
2019-05 |
TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response |
PLoS Genetics. 2019 May;15(5):Article number e1007947. |
|
2019-05 |
An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14) |
Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number 4101. |
|
2019-05 |
Oral paclitaxel in the treatment of metastatic breast cancer (MBC) patients |
Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number 1084. |
|
2019-05 |
A novel mechanism of miRNA-mediated CBX8 associated with tumorigenesis in head and neck squamous cell carcinoma |
Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number e17534. |
|
2019-05 |
Recapitulation of inflammatory and immune-evasive subtypes of oral cancer cells in immunodeficient mice |
Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number e14199. |
|
2019-04-17 |
Novel insights of lymphomagenesis of helicobacter pylori-dependent gastric mucosa-associated lymphoid tissue lymphoma |
Cancers. 2019 Apr 17;11(4):Article number 547. |
|
2019-04-12 |
Cell reprogramming in tumorigenesis and its therapeutic implications for breast cancer |
International Journal of Molecular Sciences. 2019 Apr 12;20(8):Article number 1827. |
|
2019-04-10 |
Discovery of Conformational Control Inhibitors Switching off the Activated c-KIT and Targeting a Broad Range of Clinically Relevant c-KIT Mutants |
Journal of Medicinal Chemistry. 2019 Apr 10;62(8):3940-3957. |
|
2019-04-08 |
Predominant global glomerulosclerosis in patients of upper urinary tract urothelial carcinoma with pre-existing renal function impairment is a predictor of poor renal outcomes |
BMC Cancer. 2019 Apr 8;19:Article number 337. |
|
2019-04 |
High TNFAIP6 level is associated with poor prognosis of urothelial carcinomas |
Urologic Oncology: Seminars and Original Investigations. 2019 Apr;37(4): Article number 293.e11. |
|
2019-04 |
Reply to: "Diabetes mellitus as a risk factor of hepatocellular carcinoma in patients with chronic hepatitis B on nucleot(s)ide analogues" |
Journal of Hepatology. 2019 Apr;70(4):796-797. |
|
2019-04 |
Downregulation of the cytochrome P450 4B1 protein confers a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder |
APMIS. 2019 Apr;127(4):170-180. |
|
2019-04 |
Oral hygiene and the overall survival of head and neck cancer patients |
Cancer Medicine. 2019 Apr;8(4):1854-1864. |
|
2019-04 |
Hydrodynamic shuttling for deterministic high-efficiency multiple single-cell capture in a microfluidic chip |
Lab on a Chip. 2019 Apr;19(8):1370-1377. |
|
2019-03-30 |
CD44 promotes migration and invasion of docetaxel-resistant prostate cancer cells likely via induction of hippo-yap signaling |
Cells. 2019 Mar 30;8(4):Article number 295. |
|
2019-03-21 |
Two birds, one sone: Double hits on tumor growth and lymphangiogenesis by targeting vascular endothelial growth factor receptor 3 |
Cells. 2019 Mar 21;8(3):Article number 270. |
|
2019-03-20 |
TNF-alpha-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility |
PLoS ONE. 2019 Mar 20;14(3):Article number e0213463. |
|
2019-03 |
Berbamine ameliorates isoproterenol-induced myocardial infarction by inhibiting mitochondrial dysfunction and apoptosis in rats |
Journal of Cellular Biochemistry. 2019 Mar;120(3):3101-3113. |
|
2019-03 |
Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis |
Oncogene. 2019 Mar;38(12):2005-2019. |
|
2019-03 |
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens |
Gastric Cancer. 2019 Mar;22(2):344-354. |
|
2019-03 |
Diagnosing the RGS11 lung cancer biomarker: The integration of competitive immunoassay and isothermal nucleic acid exponential amplification reaction |
Analytical Chemistry. 2019 Mar;91(5):3327-3335. |
|
2019-03 |
Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer |
Scientific Reports. 2019 Mar;9:Article number 3931. |
|
2019-03 |
Foreword |
Hepatobiliary Surgery and Nutrition. 2019 Mar;8(Suppl. 1):S1. |
|
2019-02-18 |
The potential of targeting P53 and HSP90 overcoming acquired MAPKi-Resistant melanoma |
Current Treatment Options in Oncology. 2019 Feb 18;20(3):Article number 22. |
|
2019-02-15 |
Protective effect of antrodia cinnamomea extract against irradiation-induced acute hepatitis |
International Journal of Molecular Sciences. 2019 Feb 15;20(4):Article number 846. |
|
2019-02 |
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling |
Oncogene. 2019 Feb;38(8):1340-1353. |
|
2019-02 |
The influence of prediagnosis alcohol consumption and the polymorphisms of ethanol metabolizing genes on the survival of head and neck cancer patients |
Cancer Epidemiology, Biomarkers and Prevention. 2019 Feb;28(2):248-257. |
|
2019-02 |
ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.] |
Oncogene. 2019 Feb;38(8):1354. |
|
2019-02 |
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: Interim results of a randomized, phase II trial (attraction-4) |
Annals of Oncology. 2019 Feb;30(2):250-258. |
|
2019-02 |
Identification of osteopontin as a biomarker of human exposure to fine particulate matter |
Environmental Pollution. 2019 Feb;245:975-985. |
|